Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
News Medical on MSN
AI-Driven RNA Drug Development: New Therapeutics Frontier
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...
Vietnam Investment Review on MSN
Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...
News-Medical.Net on MSN
Scientists capture real-time action of antiviral drugs on herpes
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...
Targeting SUMOylation in glioblastoma opens new avenue for therapeutic interventions and biomarker discovery Glioblastoma, a ...
This article makes a moderate such as me who voted against Trump wonder whether I can trust the Tribune newsroom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback